Back

Selective transarterial microembolization for chronic musculoskeletal pain: early and durable outcomes from a prospective cardiology-led endovascular registry

31 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: Vascular biology and interventions Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jih Tze Tan

Dalin Tzu Chi General Hospital, Chiayi (Taiwan)

4 More presentations in this session

Presentation thumbnail
Impact of vascular flow reserve and below-knee runoff on tissue perfusion after lower extremity endovascular therapy
Doctor R. Akashi (Nagasaki, JP)
Abstract
Presentation thumbnail
Sirolimus- vs. paclitaxel-coated balloons in peripheral arterial disease: a propensity score matched analysis from the real-world RECCORD registry
Doctor D. Pinsdorf (Essen, DE)
Abstract
Presentation thumbnail
Impact of smoking on premature vascular aging in a cohort of healthy men with erectile dysfunction
Doctor D. Terentes-Printzios (Athens, GR)
Abstract
Presentation thumbnail
Preprocedural HELT-E2S2 scoring identifies high cardiovascular risk after endovascular therapy in patients with lower extremity artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract

Access the full session

Session thumbnail
Vascular biology and interventions

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Anatomical, functional and pain hand assessment after transulnar artery access with ipsilateral RAO for percutaneous coronary interventions
27 August 2022
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Endovascular treatment of pulmonary embolism: experience from a tertiary center
20 March 2026
thumbnail
Congress Presentation
Association between chronic pain and incident cardiovascular disease: a nationwide prospective cohort study from the CHARLS database
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources